CHRISTINE ATCHISON: Open Payments
NPI 1760881395 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,260 in 133 payments from 26 companies in 2025. Trend: 2023 $882 · 2024 $2,134 · 2025 $2,260
Food & beverage: $2,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $324 |
| AstraZeneca Pharmaceuticals LP | 11 | $230 |
| Amgen Inc. | 14 | $228 |
| PFIZER INC. | 11 | $186 |
| Novartis Pharmaceuticals Corporation | 9 | $167 |
| Novo Nordisk Inc | 13 | $161 |
| Neurocrine BioSciences, Inc. | 10 | $152 |
| Lilly USA, LLC | 6 | $119 |
| Aimmune Therapeutics, Inc. | 6 | $101 |
| GlaxoSmithKline, LLC. | 5 | $94 |
Products named: AIRSUPRA, VRAYLAR, LEQVIO, INGREZZA, NURTEC ODT, EVENITY, ZENPEP, MOUNJARO.
Industry payments across IL — which companies pay providers there.
